HEADER LIPID BINDING PROTEIN 26-MAR-24 9ETC TITLE CRYSTAL STRUCTURE OF RECOMBINANT CHICKEN LIVER BILE ACID BINDING TITLE 2 PROTEIN (CL-BABP) IN COMPLEX WITH CHENODEOXYCHOLIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: FATTY ACID-BINDING PROTEIN, LIVER; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: FATTY ACID-BINDING PROTEIN 1,LIVER BASIC FABP,LB-FABP,LIVER COMPND 5 BILE ACID-BINDING PROTEIN,L-BABP,LIVER-TYPE FATTY ACID-BINDING COMPND 6 PROTEIN,L-FABP; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 3 ORGANISM_COMMON: CHICKEN; SOURCE 4 ORGANISM_TAXID: 9031; SOURCE 5 GENE: FABP1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS FATTY ACID BINDING PROTEIN, CHICKEN LIVER BILE ACID BINDING PROTEIN, KEYWDS 2 RECOMBINANT, BILE ACID, CHENODEOXYCHOLIC ACID, LIPID BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR G.TASSONE,C.POZZI REVDAT 1 09-OCT-24 9ETC 0 JRNL AUTH G.TASSONE,S.MARAMAI,M.PAOLINO,S.LAMPONI,F.POGGIALINI, JRNL AUTH 2 E.DREASSI,E.PETRICCI,S.ALCARO,C.POZZI,I.ROMEO JRNL TITL EXPLOITING THE BILE ACID BINDING PROTEIN AS TRANSPORTER OF A JRNL TITL 2 CHOLIC ACID/MIRIN BIOCONJUGATE FOR POTENTIAL APPLICATIONS IN JRNL TITL 3 LIVER CANCER THERAPY. JRNL REF SCI REP V. 14 22514 2024 JRNL REFN ESSN 2045-2322 JRNL PMID 39341955 JRNL DOI 10.1038/S41598-024-73636-W REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.66 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 31255 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1581 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.69 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2280 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.43 REMARK 3 BIN R VALUE (WORKING SET) : 0.3730 REMARK 3 BIN FREE R VALUE SET COUNT : 108 REMARK 3 BIN FREE R VALUE : 0.3660 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1923 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 108 REMARK 3 SOLVENT ATOMS : 237 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.91 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.109 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.119 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.107 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.380 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.969 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.947 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2071 ; 0.007 ; 0.012 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2830 ; 1.568 ; 1.643 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 249 ; 7.214 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 91 ;35.321 ;23.626 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 345 ;13.835 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 9 ; 9.973 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 313 ; 0.122 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1457 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1002 ; 3.220 ; 3.734 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1249 ; 4.458 ; 5.585 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1069 ; 4.330 ; 3.990 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 3039 ; 7.778 ;53.609 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9ETC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-APR-24. REMARK 100 THE DEPOSITION ID IS D_1292137219. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-DEC-23 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95373 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32846 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.650 REMARK 200 RESOLUTION RANGE LOW (A) : 62.670 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.04600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.74 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.85100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 200 MM SODIUM CHLORIDE, 25 % WT/VOL REMARK 280 PEG-3500 AND 100 MM HEPES, PH 7.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 281K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.38150 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 HIS B 0 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 20 CD CE NZ REMARK 470 GLU A 26 CG CD OE1 OE2 REMARK 470 ASP A 27 CG OD1 OD2 REMARK 470 ILE A 29 CG1 CG2 CD1 REMARK 470 LYS A 30 CG CD CE NZ REMARK 470 ILE A 35 CG1 CG2 CD1 REMARK 470 LYS A 44 CG CD CE NZ REMARK 470 LYS A 53 NZ REMARK 470 LYS A 77 NZ REMARK 470 LYS A 78 CE NZ REMARK 470 LYS A 96 CE NZ REMARK 470 LYS A 124 CE NZ REMARK 470 LYS B 20 CD CE NZ REMARK 470 GLU B 26 CG CD OE1 OE2 REMARK 470 LYS B 30 CG CD CE NZ REMARK 470 ARG B 33 NE CZ NH1 NH2 REMARK 470 LYS B 36 CD CE NZ REMARK 470 LYS B 44 CG CD CE NZ REMARK 470 LYS B 53 CD CE NZ REMARK 470 LYS B 78 CE NZ REMARK 470 LYS B 104 CG CD CE NZ REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 JN3 B 201 DBREF 9ETC A 1 126 UNP P80226 FABPL_CHICK 1 126 DBREF 9ETC B 1 126 UNP P80226 FABPL_CHICK 1 126 SEQADV 9ETC GLY A -2 UNP P80226 EXPRESSION TAG SEQADV 9ETC SER A -1 UNP P80226 EXPRESSION TAG SEQADV 9ETC HIS A 0 UNP P80226 EXPRESSION TAG SEQADV 9ETC GLY B -2 UNP P80226 EXPRESSION TAG SEQADV 9ETC SER B -1 UNP P80226 EXPRESSION TAG SEQADV 9ETC HIS B 0 UNP P80226 EXPRESSION TAG SEQRES 1 A 129 GLY SER HIS MET ALA PHE SER GLY THR TRP GLN VAL TYR SEQRES 2 A 129 ALA GLN GLU ASN TYR GLU GLU PHE LEU LYS ALA LEU ALA SEQRES 3 A 129 LEU PRO GLU ASP LEU ILE LYS MET ALA ARG ASP ILE LYS SEQRES 4 A 129 PRO ILE VAL GLU ILE GLN GLN LYS GLY ASP ASP PHE VAL SEQRES 5 A 129 VAL THR SER LYS THR PRO ARG GLN THR VAL THR ASN SER SEQRES 6 A 129 PHE THR LEU GLY LYS GLU ALA ASP ILE THR THR MET ASP SEQRES 7 A 129 GLY LYS LYS LEU LYS CYS THR VAL HIS LEU ALA ASN GLY SEQRES 8 A 129 LYS LEU VAL THR LYS SER GLU LYS PHE SER HIS GLU GLN SEQRES 9 A 129 GLU VAL LYS GLY ASN GLU MET VAL GLU THR ILE THR PHE SEQRES 10 A 129 GLY GLY VAL THR LEU ILE ARG ARG SER LYS ARG VAL SEQRES 1 B 129 GLY SER HIS MET ALA PHE SER GLY THR TRP GLN VAL TYR SEQRES 2 B 129 ALA GLN GLU ASN TYR GLU GLU PHE LEU LYS ALA LEU ALA SEQRES 3 B 129 LEU PRO GLU ASP LEU ILE LYS MET ALA ARG ASP ILE LYS SEQRES 4 B 129 PRO ILE VAL GLU ILE GLN GLN LYS GLY ASP ASP PHE VAL SEQRES 5 B 129 VAL THR SER LYS THR PRO ARG GLN THR VAL THR ASN SER SEQRES 6 B 129 PHE THR LEU GLY LYS GLU ALA ASP ILE THR THR MET ASP SEQRES 7 B 129 GLY LYS LYS LEU LYS CYS THR VAL HIS LEU ALA ASN GLY SEQRES 8 B 129 LYS LEU VAL THR LYS SER GLU LYS PHE SER HIS GLU GLN SEQRES 9 B 129 GLU VAL LYS GLY ASN GLU MET VAL GLU THR ILE THR PHE SEQRES 10 B 129 GLY GLY VAL THR LEU ILE ARG ARG SER LYS ARG VAL HET JN3 A 201 28 HET JN3 A 202 28 HET JN3 B 201 24 HET JN3 B 202 28 HETNAM JN3 CHENODEOXYCHOLIC ACID HETSYN JN3 (3ALPHA,5ALPHA,7BETA,8ALPHA,17ALPHA)-3,7- HETSYN 2 JN3 DIHYDROXYCHOLAN-24-OIC ACID FORMUL 3 JN3 4(C24 H40 O4) FORMUL 7 HOH *237(H2 O) HELIX 1 AA1 ASN A 14 LEU A 22 1 9 HELIX 2 AA2 PRO A 25 ARG A 33 1 9 HELIX 3 AA3 ASN B 14 LEU B 22 1 9 HELIX 4 AA4 PRO B 25 ARG B 33 1 9 SHEET 1 AA1 9 THR A 58 THR A 64 0 SHEET 2 AA1 9 ASP A 47 LYS A 53 -1 N PHE A 48 O PHE A 63 SHEET 3 AA1 9 ILE A 38 LYS A 44 -1 N GLN A 42 O VAL A 49 SHEET 4 AA1 9 GLY A 5 GLU A 13 -1 N TRP A 7 O VAL A 39 SHEET 5 AA1 9 VAL A 117 ARG A 125 -1 O ARG A 122 N ALA A 11 SHEET 6 AA1 9 GLU A 107 PHE A 114 -1 N ILE A 112 O LEU A 119 SHEET 7 AA1 9 PHE A 97 LYS A 104 -1 N LYS A 104 O GLU A 107 SHEET 8 AA1 9 LYS A 89 LYS A 93 -1 N THR A 92 O HIS A 99 SHEET 9 AA1 9 VAL A 83 ALA A 86 -1 N HIS A 84 O VAL A 91 SHEET 1 AA2 2 ALA A 69 THR A 72 0 SHEET 2 AA2 2 LYS A 78 CYS A 81 -1 O LEU A 79 N ILE A 71 SHEET 1 AA3 9 THR B 58 THR B 64 0 SHEET 2 AA3 9 ASP B 47 LYS B 53 -1 N PHE B 48 O PHE B 63 SHEET 3 AA3 9 ILE B 38 LYS B 44 -1 N GLU B 40 O THR B 51 SHEET 4 AA3 9 GLY B 5 GLU B 13 -1 N TRP B 7 O VAL B 39 SHEET 5 AA3 9 VAL B 117 ARG B 125 -1 O ARG B 122 N ALA B 11 SHEET 6 AA3 9 GLU B 107 PHE B 114 -1 N ILE B 112 O LEU B 119 SHEET 7 AA3 9 PHE B 97 LYS B 104 -1 N LYS B 104 O GLU B 107 SHEET 8 AA3 9 LYS B 89 LYS B 93 -1 N THR B 92 O HIS B 99 SHEET 9 AA3 9 VAL B 83 ALA B 86 -1 N HIS B 84 O VAL B 91 SHEET 1 AA4 2 ALA B 69 THR B 72 0 SHEET 2 AA4 2 LYS B 78 CYS B 81 -1 O CYS B 81 N ALA B 69 CRYST1 36.564 60.763 63.546 90.00 99.55 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027349 0.000000 0.004599 0.00000 SCALE2 0.000000 0.016457 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015958 0.00000